Acute effect of low-flux hemodialysis process on the results of the interferon-gamma-based QuantiFERON®-TB Gold In-Tube test in end-stage renal disease patients

Transplant Infectious Disease

Volumn 11, Issue 1, 2009, Pages 28-32

  Hursitoglu, M ^a   Cikrikcioglu, M A ^a   Tukek, T ^a   Beycan, I ^a   Ahmedova, N ^b   Karacuha, S ^b   Sansal, M ^a   Ozkan, O ^a   Celik, V ^b  

^a VAKIF GUREBA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Gunes Dialysis Center   (Turkey)

Author keywords

End stage renal disease; Interferon release assay; Low flux hemodialysis; Mycobacterium tuberculosis; QuantiFERON test

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTIFERON TB GOLD IN TUBE TEST;

ADULT; ANTIGENS, BACTERIAL; FEMALE; HUMANS; INTERFERON-GAMMA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; RENAL DIALYSIS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 58649120508     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2008.00348.x     Document Type: Article

References (21)

1. Klote MM, Agodoa LY, Abbott K. Mycobacterium tuberculosis infection incidence in hospitalized renal transplant patients in the United States, 1998-2000. Am J Transplant 2004 4 : 1523 1528.
2. Woeltje KF, Mathew A, Rothstein M, et al. Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis 1998 31 : 848 852.
3. Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M. Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-Spot.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol 2007 2 : 68 73.
4. Mazurek GH, Jereb J, LoBue P, et al. Guidelines for using Quantiferon-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005 54 : 49 55.
5. ®-TB Gold package insert. Available at website.
6. Manuel O, Humar A, Preiksaitis J, et al. Comparison of Quantiferon-TB Gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007 7 : 2797 2801.
7. Lonnemann G, Novick D, Rubinstein M, Dinarello CA. Interleukin-18, interleukin-18 binding protein and impaired production of interferon-gamma in chronic renal failure. Clin Nephrol 2003 60 : 327 334.
8. Lonnemann G, Novick D, Rubinstein M, et al. A switch to high-flux helixone membranes reverses suppressed interferon-gamma production in patients on low-flux dialysis. Blood Purif 2003 21 : 225 2231.
9. National Kidney Foundation K/DOQI Guidelines. 2000. Available at.
10. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFeron TB-2G test for immunocompromised patients. Eur Respir J 2007 30 : 945 950.
11. Wu HP, Hua CC, Liu YC, Chuang DY. Comparison of interferon-γ response between tuberculosis and non-tubercular pneumonia. Inflamm Res 2007 56 : 11 16.
12. Biolo G, Amoroso A, Savoldi S, et al. Association of interferon- γ+874A polymorphism with reduced long-term inflammatory response in hemodialysis patients. Nephrol Dial Transplant 2006 21 : 1317 1322.
13. Lonnemann G, Barndt I, Kaever V, et al. Impaired endotoxin-induced interleukin-1β secretion, not total production of mononuclear cells from ESRD patients. Kidney Int 1995 47 : 1158 1167.
14. Ayli D, Ayli M, Azak A, et al. The effect of high-flux hemodialysis on renal anemia. J Nephrol 2004 17 : 701 706.
15. Traut M, Haufe CC, Eismann U, Deppish RM, Stein G, Wolf G. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialysis compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study. Blood Purif 2007 25 : 432 440.
16. Zachwieja J, Zaniew M, Runowski D, et al. Abnormal cytokine synthesis as a consequence of increased intracellular oxidative stress in children treated with dialysis. Nephron Clin Pract 2005 101 : c100 c108.
17. Fulton SA, Johnsen JM, Wolf SF, Sieburth DS, Boom WH. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun 1996 64 : 2523 2531.
18. Sester U, Sester M, Heine G, Kaul H, Girndt M, Köhler H. Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment. Nephrol Dial Transplant 2001 16 : 1402 1408.
19. Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, et al. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 2008 35 : 776 781.
20. Soysal A, Torun T, Efe S, Gencer H, Tahaoglu K, Bakir M. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection. Int J Tuberc Lung Dis 2008 12 : 50 56.
21. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection. An interferon-γ-based assay using new antigens. Am J Respir Crit Care Med 2004 170 : 59 64.